The FDA has removed a pause in the use of Valneva’s chikungunya vaccine in older adults while tweaking the shot’s label with ...

Bavarian Nordic’s stock soared 10% on Thursday after the Danish biotech company posted better-than-expected second-quarter earnings and unveiled an order for 440,000 doses of smallpox and mpox ...

The US Food and Drug Administration (FDA) has lifted a pause in the use of Valneva’s chikungunya vaccine Ixchiq in older adults after a benefit-risk reevaluation, though the move comes with an ...

Human monoclonal antibodies targeting rabies glycoprotein have been proposed as a potential alternative to rabies immunoglobulin to neutralise rabies virus at the wound site until sufficient virus ...

The outlook for the gastric cancer treatment market appears favorable, fueled by progress in targeted therapies and immunotherapies. Traditionally, p ...

The global biodefense market size was US$ 13.7 billion in 2021. The global biodefense market size is forecast to reach US$ 33.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.0% ...

The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today ...

Freshfields has advised Permira and Nordic Capital on their all-cash, voluntary, and recommended public takeover offer for Bavarian Nordic.